Cargando…

Butyrate producing microbiota are reduced in chronic kidney diseases

Chronic kidney disease is a major public health concern that affects millions of people globally. Alterations in gut microbiota composition have been observed in patients with chronic kidney disease. Nevertheless, the correlation between the gut microbiota and disease severity has not been investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Bei, Jose, Adarsh, Alonzo-Palma, Norma, Malik, Taimur, Shankaranarayanan, Divya, Regunathan-Shenk, Renu, Raj, Dominic S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651744/
https://www.ncbi.nlm.nih.gov/pubmed/34876615
http://dx.doi.org/10.1038/s41598-021-02865-0
Descripción
Sumario:Chronic kidney disease is a major public health concern that affects millions of people globally. Alterations in gut microbiota composition have been observed in patients with chronic kidney disease. Nevertheless, the correlation between the gut microbiota and disease severity has not been investigated. In this study, we performed shot-gun metagenomics sequencing and identified several taxonomic and functional signatures associated with disease severity in patients with chronic kidney disease. We noted that 19 microbial genera were significantly associated with the severity of chronic kidney disease. The butyrate-producing bacteria were reduced in patients with advanced stages of chronic kidney diseases. In addition, functional metagenomics showed that two-component systems, metabolic activity and regulation of co-factor were significantly associated with the disease severity. Our study provides valuable information for the development of microbiota-oriented therapeutic strategies for chronic kidney disease.